Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;148(6 Suppl 1):1-10.

Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning

P Gisondi  1 , P Amerio, G F Amoroso, V A Antonucci, F Bardazzi, M R Buongiorno, P Bruni, A Campanati, M Caproni, M Carlesimo, C G Carrera, G Cianchino, G Cimmino, A Costanzo, E Cozzani, P Dapavo, D D'amico, C De Simone, M Del Giglio, S Di Nuzzo, F Gai, A G Galluccio, A Goffredo, G Gualdi, C Guarneri, F Kokelj, C Lasagni, F Loconsole, V Longo, P Malagoli, A Miracapillo, C Mugheddu, A Parodi, M Pellegrino, A Peserico, S Piaserico, G Pistone, C Potenza, A Plumari, L Stingeni, D Strippoli, M Travaglino, G Girolomoni
Affiliations
  • PMID: 24675369

Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning

P Gisondi et al. G Ital Dermatol Venereol. 2013 Dec.

Abstract

Aim: The aim of this study was to provide practical recommendations for optimizing the use of conventional and biological systemic treatments for moderate-severe chronic plaque psoriasis, particularly in case of transitioning and switching.

Methods: A total number of 147 dermatologists from 33 different countries including Italy achieved consensus in providing practical recommendations for the use of conventional and biological treatments for moderate to severe psoriasis based on systematic literature review and/or expert opinion.

Results: In general, the continuous treatment regimen should be preferred in order to achieve a complete and long-term control of psoriasis. However, the treatment could be stopped or the dose reduced in case of complete disease clearance. A conventional drug could be associated to biological treatment in selected cases. Transitioning and/or switching could be considered in case of inefficacy or intolerance. A period of wash up is required if transitioning or switching is due to safety issues.

Conclusion: This study provides practical suggestions for the optimal use of conventional and biological treatments for chronic plaque psoriasis.

PubMed Disclaimer

LinkOut - more resources